(EUNZ) iShares Edge MSCI EM - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B8KGV557 • Global Emerging Markets Equity

EUNZ: Stocks, Bonds, Emerging Markets, Equities

The iShares Edge MSCI EM Minimum Volatility UCITS ETF USD (Acc) EUR (EUNZ) is an exchange-traded fund listed on XETRA, designed to track the Morningstar EM TME NR USD Index. This index focuses on emerging market equities, employing a minimum volatility strategy to reduce overall portfolio risk while aiming to capture market returns. The fund is structured as a UCITS-compliant ETF, making it accessible to European investors seeking exposure to global emerging markets with a risk-mitigating approach.

From a technical perspective, EUNZ is currently trading at 32.77 EUR, slightly below its 20-day SMA of 33.37 and 50-day SMA of 33.16, indicating recent price weakness. The 200-day SMA of 31.89 suggests the fund has been in an upward trend over the longer term, despite short-term fluctuations. Average daily trading volume over the past 20 days stands at 5,301 shares, reflecting moderate liquidity. The ATR of 0.28 indicates relatively tight price ranges, aligning with the funds low-volatility objective.

Fundamentally, EUNZ manages an AUM of 284.86M EUR, signaling a well-established ETF with significant investor interest. The funds focus on minimum volatility within emerging markets positions it as a defensive play, appealing to risk-averse investors seeking participation in higher-growth markets without exposure to excessive price swings. The underlying Morningstar index employs a systematic approach to select and weight securities, aiming to deliver a lower-volatility portfolio compared to the broader emerging market universe.

Over the next three months, EUNZ is expected to face headwinds due to its current price position below the 20-day and 50-day SMAs, which may indicate near-term weakness. However, the funds low ATR and alignment with its minimum volatility strategy suggest potential stabilization as markets adjust to broader macroeconomic conditions. The AUM level indicates sustained investor confidence, which could support the funds resilience during periods of market uncertainty. The interplay between technical momentum and the fundamental appeal of its risk-mitigating strategy will likely shape its performance in the coming quarter.

Additional Sources for EUNZ ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EUNZ ETF Overview

Market Cap in USD 309m
Category Global Emerging Markets Equity
TER 0.40%
IPO / Inception 2012-11-30

EUNZ ETF Ratings

Growth 5y 64.6%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -16.3
Analysts -
Fair Price Momentum 30.63 EUR
Fair Price DCF -

EUNZ Dividends

No Dividends Paid

EUNZ Growth Ratios

Growth Correlation 3m -17.8%
Growth Correlation 12m 89%
Growth Correlation 5y 64.1%
CAGR 5y 8.46%
CAGR/Max DD 5y 0.67
Sharpe Ratio 12m 0.87
Alpha 1.30
Beta 0.35
Volatility 12.71%
Current Volume 7.2k
Average Volume 20d 5k
What is the price of EUNZ stocks?
As of March 15, 2025, the stock is trading at EUR 31.80 with a total of 7,220 shares traded.
Over the past week, the price has changed by +0.52%, over one month by -4.59%, over three months by -4.00% and over the past year by +6.73%.
Is iShares Edge MSCI EM a good stock to buy?
Yes. Based on ValueRay Analyses, iShares Edge MSCI EM (XETRA:EUNZ) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 64.55 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EUNZ as of March 2025 is 30.63. This means that EUNZ is currently overvalued and has a potential downside of -3.68%.
Is EUNZ a buy, sell or hold?
iShares Edge MSCI EM has no consensus analysts rating.
What are the forecast for EUNZ stock price target?
According to ValueRays Forecast Model, EUNZ iShares Edge MSCI EM will be worth about 33.6 in March 2026. The stock is currently trading at 31.80. This means that the stock has a potential upside of +5.63%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 33.6 5.6%